# FDA Inspection 1091302 - Recipharm Leganes SLU - October 05, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/recipharm-leganes-slu/3153c89e-15c0-45e7-a8ec-1310fab8ec84
Source feed: FDA_Inspections

> FDA Inspection 1091302 for Recipharm Leganes SLU on October 05, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091302
- Company Name: Recipharm Leganes SLU
- Inspection Date: 2017-10-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261202 - 2023-10-26](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-leganes-slu/3258bd7c-ec18-4a79-9b7b-e0e57fb53ea8)
- [FDA Inspection 992010 - 2016-10-14](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-leganes-slu/0fcb0dc3-9a30-4e22-872a-f04a47d3fc8b)
- [FDA Inspection 868277 - 2014-01-31](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-leganes-slu/b28cef23-09db-41b7-b8e1-165b25162101)
- [FDA Inspection 651878 - 2010-02-05](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-leganes-slu/5c67dfe0-7a50-45bd-b63b-740d367fb44d)

Company: https://www.globalkeysolutions.net/companies/recipharm-leganes-slu/367c3c27-e4b8-429e-be41-9018a0900cf1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c